Same Indication

Methylprednisolone vs Rituximab

Methylprednisolone vs Rituximab: Overview

This comparison examines the pharmacological differences between Methylprednisolone and Rituximab.

Mechanism of Action

Methylprednisolone: Intermediate-acting synthetic glucocorticoid.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Methylprednisolone — 18-36 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Methylprednisolone — C22H30O5.

Molecular Weight: Methylprednisolone — 374.4710 g/mol.

Type: Methylprednisolone — Small molecule; Rituximab — Antibody.